Stock Events

Stock Events

Aardvark Therapeutics (AARD) Q3 2025 Earnings

13AugConfirmed

Q2 2025

Q3 2025

-0.71

-0.67

-0.64

-0.6

Details

Expected EPS

-0.6

Actual EPS

-0.66

Surprise EPS

-0.06

Surprise Percent

+10%

Description

Aardvark Therapeutics (AARD) has reported earnings of -0.66 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.